Although KOR agonists could somehow inhibit the positive reinforcement process during a SUD development (Shippenberg and Rea, 1997), once dependence and tolerance are established, the best therapeutic strategy remains KOR antagonists that reduce the relapse related to withdrawal-induced anxiety. This evidence concerns the gene OPRK1 and Anxiety.